Patent · US Active

Immunomodulatory peptide

US12365709B2 · kind B2 · utility

0Cited by
2References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 3, 2023
Grant dateJul 22, 2025
Priority date
Expiry dateAug 3, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to an isolated peptide consisting of a sequence of 3 to 39 amino acids derived from the amino acid sequence SEQ ID NO: 1, said peptide having a sequence of amino acids selected from the group consisting of:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.